2014
DOI: 10.2147/ppa.s68299
|View full text |Cite
|
Sign up to set email alerts
|

Experience and levels of satisfaction with the levonorgestrel-releasing intrauterine system in China: a prospective multicenter survey

Abstract: BackgroundAlthough surveys conducted in Western countries have shown that the levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena®) is well accepted by European women, its acceptance by Chinese women is not yet clearly known. The purpose of this study was to analyze the experiences and levels of satisfaction with Mirena among Chinese women living in 12 different cities.MethodsIn total, 1,021 women who attended 21 medical centers for insertion of Mirena were invited to complete a questionnaire regardi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(13 citation statements)
references
References 11 publications
1
10
0
Order By: Relevance
“…Similarly, Abraham et al found that nulliparous women were more likely to discontinue Cu-IUS and implants than parous, but it was not reported for the group consisting of LNG-IUS users [30]. This finding was also confirmed by other authors [32,49,52]. In a study conducted by Teunissen et al, continuation rates in women with parity ≥ 2 were noticeably higher than in nulliparous ones at all follow-up visits (first year-77% vs. 81%; second year-64% vs. 72%; third year-50% vs. 65%; fourth year-38% vs. 59%; fifth year-11% vs. 24%; authors did not specify the level of statistical significance for those differences) [47].…”
Section: Continuationmentioning
confidence: 68%
See 1 more Smart Citation
“…Similarly, Abraham et al found that nulliparous women were more likely to discontinue Cu-IUS and implants than parous, but it was not reported for the group consisting of LNG-IUS users [30]. This finding was also confirmed by other authors [32,49,52]. In a study conducted by Teunissen et al, continuation rates in women with parity ≥ 2 were noticeably higher than in nulliparous ones at all follow-up visits (first year-77% vs. 81%; second year-64% vs. 72%; third year-50% vs. 65%; fourth year-38% vs. 59%; fifth year-11% vs. 24%; authors did not specify the level of statistical significance for those differences) [47].…”
Section: Continuationmentioning
confidence: 68%
“…A total of 15 out of 23 articles reported data on the continuation rates in the studied population [30][31][32][35][36][37]39,41,43,45,[47][48][49]51,52] (Table 3). In the studies assessing the rate of continuing treatment after the first year, continuation rates ranged from 73% (Kaislasuo et al) up to 93% (Hall et al).…”
Section: Continuationmentioning
confidence: 99%
“…Later, the copper-releasing IUDs replaced the steel rings as many problems were encountered by using the rings [ 29 ].Nowadays, copper-releasing IUDs have become the prevailing devices in clinical application in China [ 22 , 24 ]. Recently, the levonorgestrel intrauterine system (LNG-IUS) along with other optimized IUDs were also provided to Chinese women [ 25 ]. In this study, the majority of devices that induced uterine perforation were copper-releasing IUDs with T-shaped copper ( n = 10) followed by V-shaped copper IUDs ( n = 13) and four of those with O-shaped IUDs (Table 1 ).…”
Section: Discussionmentioning
confidence: 99%
“…Most of the IUDs used in China are manufactured in China, and the majority is the copper-releasing IUDs, including all types of T-shaped and V-shaped copper-releasing IUDs. Recently, some overseas products, as LNG-IUS [ 25 ] and GyneFix [ 26 ], have also been introduced to China.…”
Section: Introductionmentioning
confidence: 99%
“…Similar to this study, previous studies from Western countries have reported a lack of awareness and misconceptions among HCPs regarding the unsuitability of IUD in certain groups of women, levying a substantial impact on the IUD use [ 19 ]. In addition, LNGIUS use in this study was low (0.5%), despite its availability in the Chinese market since 2000 and high satisfaction rates among Chinese women [ 20 ]. The reason for the low prevalence may be the high price, which is not covered under the health insurance schemes.…”
Section: Discussionmentioning
confidence: 99%